Clinicopathologic characteristics and treatment of marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)

CA: a Cancer Journal for Clinicians
Markus RadererAndrés J M Ferreri

Abstract

Extranodal marginal zone lymphoma of the mucosa-associated lymphoid tissue (MALT lymphoma) accounts for 7% to 8% of newly diagnosed lymphomas. Because of its association with infectious causes, such as Helicobacter pylori (HP) or Chlamydophila psittaci (CP), and autoimmune diseases, it has become the paradigm of an antigen-driven malignancy. MALT lymphoma usually displays an indolent course, and watch-and-wait strategies are justified initially in a certain percentage of patients. In patients with gastric MALT lymphoma or ocular adnexal MALT lymphoma, antibiotic therapy against HP or CP, respectively, is the first-line management of choice, resulting in lymphoma response rates from 75% to 80% after HP eradication and from 33% to 65% after antibiotic therapy for CP. In patients who have localized disease that is refractory to antibiotics, radiation is widely applied in various centers with excellent local control, whereas systemic therapies are increasingly being applied, at least in Europe, because of the potentially systemic nature of the disease. Therefore, the objective of this review is to briefly summarize the clinicopathologic characteristics of this distinct type of lymphoma along with current data on management strategies.

References

Nov 1, 1990·American Journal of Clinical Pathology·A C WotherspoonP G Isaacson
Oct 1, 1995·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P HammelJ C Delchier
Apr 1, 1995·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C MontalbánJ Menarguez
May 1, 1994·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A RohatinerM Shipp
Dec 1, 1993·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C TondiniA J Ferreri
May 5, 1994·The New England Journal of Medicine·J ParsonnetG D Friedman
Sep 1, 1995·Current Opinion in Oncology·C ThieblemontB Coiffier
Jun 1, 1996·Alimentary Pharmacology & Therapeutics·W DickeyJ B McConnell
Jan 1, 1997·The Journal of Investigative Dermatology·R N PickenM M Picken
Apr 1, 1997·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C ThieblemontB Coiffier
Dec 24, 1997·Annals of Oncology : Official Journal of the European Society for Medical Oncology·I A AuerD E Horsman
Aug 12, 1999·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P G Isaacson
Feb 9, 2000·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·P ZenahlikL Cerroni
Feb 7, 2001·Virchows Archiv : an International Journal of Pathology·B SchmausserH K Müller-Hermelink
Nov 7, 2000·Genes, Chromosomes & Cancer·R AchuthanK A MacLennan
Sep 14, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gerald JägerMarkus Raderer
Nov 29, 2002·Blood·Emanuele ZuccaUNKNOWN International Extranodal Lymphoma Study Group
Feb 1, 2003·Blood·Dolors Sanchez-IzquierdoJose Angel Martinez-Climent
Feb 20, 2003·The American Journal of Gastroenterology·Philippe LehoursUNKNOWN Groupe d'Etude des Lymphomes Digestifs (GELD) for the Fédération Française de Cancérologie Digestive (FFCD)
May 13, 2003·Gut·A Ruskoné-FourmestrauxD De Jong
Jun 18, 2003·The American Journal of Gastroenterology·David Y GrahamHala M T El-Zimaity
Nov 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Richard W TsangBruce J Patterson
Jun 5, 2004·Ophthalmology·Toshihiko Matsuo, Tadashi Yoshino
Nov 2, 2004·Nature Reviews. Immunology·Paul J Coffer, Boudewijn M T Burgering
Jan 26, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giovanni MartinelliEmanuele Zucca

❮ Previous
Next ❯

Citations

Aug 22, 2016·Journal of Cancer Research and Clinical Oncology·Susann StollbergAmelie Lupp
Sep 14, 2016·European Journal of Nuclear Medicine and Molecular Imaging·Domenico AlbanoFrancesco Bertagna
Mar 9, 2017·Leukemia & Lymphoma·Domenico AlbanoFrancesco Bertagna
Apr 28, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Manali K Kamdar, Sonali M Smith
Jun 8, 2017·Hematological Oncology·Markus Raderer
Mar 16, 2017·Best Practice & Research. Clinical Haematology·Marianna SassoneAndrés J M Ferreri
May 22, 2018·Cancer Control : Journal of the Moffitt Cancer Center·Luis Miguel Juárez-SalcedoSamir Dalia
Dec 21, 2017·Future Oncology·Cecilia B RosandJean L Koff
Jul 28, 2017·Ophthalmic Plastic and Reconstructive Surgery·Eun Jung SohnYoon Hyung Kwon
Jul 25, 2018·The British Journal of Radiology·Dominik BerzaczyMarius E Mayerhoefer
Jan 24, 2019·Clinical Nuclear Medicine·Qingqing PanFang Li
Dec 6, 2017·International Journal of Rheumatic Diseases·Yu-Hsuan ShihChieh-Lin Jerry Teng
May 24, 2020·British Journal of Haematology·Maria CondomEva Domingo-Domenech
May 30, 2020·Hematological Oncology·Barbara Kiesewetter, Markus Raderer
Jul 1, 2020·Scandinavian Journal of Immunology·Dragan Marinkovic, Tatjana Marinkovic
Oct 12, 2017·European Radiology·Massimo GaliaRoberto Lagalla
Oct 4, 2017·World Journal of Gastroenterology : WJG·Masaya IwamuroHiroyuki Okada
Jun 9, 2020·Case Reports in Medicine·Lucy NavsariaMichael Wang
Aug 24, 2017·The British Journal of Radiology·Domenico AlbanoFrancesco Bertagna
Mar 9, 2019·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Marius E MayerhoeferMarkus Raderer
Oct 9, 2020·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Antonio TravaglinoMassimo Mascolo
Sep 20, 2020·Journal of Crohn's & Colitis·Marie MullerLaurent Peyrin-Biroulet

Dec 30, 2020·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Antonio TravaglinoMassimo Mascolo
Dec 15, 2020·International Journal of Radiation Oncology, Biology, Physics·Penny FangBouthaina S Dabaja

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Atrophic Gastritis

Atrophic Gastritis is a process where gastric glandular cells are lost and replaced with firbous tissues, as a result of chronic inflammation. Learn more about Atrophic Gastritis here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

CNS Lymphoma

In CNS lymphoma, cancerous cells from lymph tissues or other parts of the body form tumors in the brain and/or spinal cord. Here is the latest research on this rare non-Hodgkin lymphoma.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.